SAINT-GOBAIN DIVESTS ITS
TREATED TIMBER BUSINESSES IN THE UK & IRELAND
Saint-Gobain has signed a binding agreement for the sale of its treated timber products (utility poles, fencing and railway sleepers) manufacturing brands: PDM in Ireland and Calders & Grandidge in the UK - to the Iivari Mononen Group.
The divested assets, comprising two business units in Ireland and the UK, generated revenues of ?50 million in 2023 and employ 80 people.
The divestment of PDM completed today, and the sale of Calders & Grandidge is expected to be completed by the end of 2024, subject to competition authority clearance.
These divestments are part of Saint-Gobain's continued business profile optimization strategy, in line with its "Grow & Impact" plan.
About Saint-Gobain
Worldwide leader in light and sustainable construction, Saint-Gobain designs, manufactures and distributes materials and services for the construction and industrial markets. Its integrated solutions for the renovation of public and private buildings, light construction and the decarbonization of construction and industry are developed through a continuous innovation process and provide sustainability and performance. The Group's commitment is guided by its purpose, "MAKING THE WORLD A BETTER HOME".
?47.9 billion in sales in 2023
160,000 employees, locations in 76 countries
Committed to achieving Carbon Neutrality by 2050
For more information about Saint-Gobain, visit www.saint-gobain.com and follow us on X @saintgobain
Analyst/investor relations | Press relations | ||
Vivien Dardel: | +33 1 88 54 29 77 | Patricia Marie: | +33 1 88 54 26 83 |
Floriana Michalowska: | +33 1 88 54 19 09 | Laure Bencheikh: | +33 1 88 54 26 38 |
Alix Sicaud: | +33 1 88 54 38 70 | | |
James Weston: | +33 1 88 54 01 24 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.